Health equity has become a central focus in U.S. healthcare policy, as disparities in access, affordability, and outcomes continue to affect vulnerable populations. The Inflation Reduction Act (IRA) introduces sweeping changes to drug pricing and Medicare negotiations‚ reforms designed to lower costs, but with implications that extend far beyond economics. These changes raise important questions: How will pricing reforms impact access for underserved communities? Will value-based frameworks help close gaps in care or create new barriers?

Watch this webinar to explore how policy shifts under the IRA intersect with health equity, what challenges remain, and what strategies stakeholders are using to promote fairness in access and affordability. If you don't have time to watch the entire event, we also invite you to download the Summary eBook from the handouts tab in the webinar recording player to access the concise summary of the presentation and access important resources from our sponsors:

Identifying Disparities with Real-World Data: Structured, Unstructured, and Social Determinants of Health

Michael Munsell, PhD
Director
Real World Data HEOR
Norstella

How the IRA Could Influence R&D Pipelines and Investment

Haripriya Jain, MS, MBA
Executive Director
PPD Evidera Health Economics and Market Access
Thermo Fisher Scientific